ConductScience.org, home

Paper3000290

Effect of pyrimidinone treatment on lethal and immunosuppressive murine cytomegalovirus infection.

Brideau RJ and 1 other. Antimicrob Agents Chemother, 1985. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Effect of pyrimidinone treatment on lethal and immunosuppressive murine cytomegalovirus infection. Papers, record 3000290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3000290

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of pyrimidinone treatment on lethal and immunosuppressive murine cytomegalovirus infection.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brideau RJR J
2Wolcott JAJ A

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytomegalovirus InfectionsMajor topic
Immune ToleranceMajor topic
PyrimidinonesMajor topic
Animals
Animals, Newborn
Female
Lymphocyte Activation
Mice
Mice, Inbred BALB C
Mice, Inbred ICR
Mitogens
Spleen
Viral Plaque Assay

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1176935Effect of cytosine arabinoside and 5-iodo-2'-deoxyuridine on a cytomegalovirus infection in newborn mice.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/176935PubMed
2879763Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/879763PubMed
3210231Correlation of the suppression of mitogen responsiveness and the mixed lymphocyte reaction with the proliferative response to viral antigen of splenic lymphocytes from cytomegalovirus-infected mice.J Immunol1978https://conductscience.org/library/papers/210231PubMed
4436406A computer program for testing average partial association in three-way contingency tables (PARCAT).Comput Programs Biomed1979https://conductscience.org/library/papers/436406PubMed
573657395-substituted 2-amino-6-phenyl-4(3H)-pyrimidinones. Antiviral- and interferon-inducing agents.J Med Chem1980https://conductscience.org/library/papers/7365739PubMed
66257788Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance.J Immunol1981https://conductscience.org/library/papers/6257788PubMed
76329371Therapeutic approaches to the control of cytomegalovirus infections.Birth Defects Orig Artic Ser1984https://conductscience.org/library/papers/6329371PubMed
86272627Activity of trifluorothymidine against cytomegalovirus.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6272627PubMed
96286802Interferon induction by 5-halo-6-phenyl pyrimidinones.J Interferon Res1980https://conductscience.org/library/papers/6286802PubMed
1068486035-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.J Immunol1983https://conductscience.org/library/papers/6848603PubMed
116202880Protective effect of biological response modifiers on murine cytomegalovirus infection.J Virol1984https://conductscience.org/library/papers/6202880PubMed
126203569Immunology of cytomegalovirus: immunosuppressive effects during infections.Birth Defects Orig Artic Ser1984https://conductscience.org/library/papers/6203569PubMed
136262407Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.J Immunol1981https://conductscience.org/library/papers/6262407PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
3257900In vivo generation of lymphokine activated killer cell activity by ABPP and interleukin-2 and their antitumor effects against immunogenic and nonimmunogenic tumors in murine tumor models.Cancer Immunol Immunother1988https://conductscience.org/library/papers/3257900PubMed
2820635Pyrimidinone (bropirimine) mediated alteration of T lymphocyte subsets during murine cytomegalovirus infection.Clin Exp Immunol1987https://conductscience.org/library/papers/2820635PubMed
2817849Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2817849PubMed
1329629Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1329629PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3000290

GET https://conductscience.org/api/papers/v1/3000290/authors